Target intelligence / Profile preview

Splicing factor 3B subunit 3 (SF3B3)

Target
SF3B3
Molecular classification
Spliceosome component, RNA-binding protein, Chromatin-modifying complex subunit (STAGA/TFTC)
01

Overview

Splicing factor 3B subunit 3 (SF3B3) is a core component of the SF3b protein complex, which together with SF3a and U2 small nuclear RNA forms the U2 small nuclear ribonucleoprotein (snRNP) complex. SF3B3 plays essential roles in recognizing branch point sequences during pre-mRNA splicing, anchoring U2 snRNP to pre-mRNA, and facilitating spliceosome assembly and activation. It also participates in the minor U12-type spliceosome, and is a subunit of chromatin-modifying complexes like STAGA and TFTC, linking it to transcription regulation and DNA repair. Dysregulation or mutation of SF3B3 is implicated in cancer and inherited syndromes, and it is a direct target for small-molecule splicing modulators such as E7107

Other names
SF3B3SAP130SF3b130RSE1STAF130KIAA0017Spliceosome-associated protein 130Pre-mRNA-splicing factor SF3b 130 kDa subunit
02

Mechanism of action

Competitive inhibition of branch point sequence binding in the spliceosome by occupying the BPA-binding pocket (e.g., E7107 modulates splicing by binding SF3b complex, disrupting pre-mRNA substrate recognition)

03

Biological functions

Pre-mRNA splicing (removal of introns, branch site recognition)Assembly and activation of the spliceosomeChromatin modificationTranscriptional regulationDNA repair
04

Disease associations

Cancer (e.g., prostate cancer)Oculopharyngodistal myopathy 1Zika virus infectious diseaseTietz syndromeWaardenburg syndrome (type IIa 2F, type 2A)Lattice corneal dystrophy type IUncombable hair syndrome
05

Safety considerations

Off-target splicing modulation (risk of widespread aberrant splicing)Myelosuppression and other toxicity reported with splicing modulators (e.g., E7107 clinical trials)
06

Interacting drugs

E7107

1 more in the full profile.

07

Biomarkers

Splicing patterns (alternative splicing events)SF3B3 expression (potentially in cancer)Spliceosome activity (used in efficacy monitoring for splicing modulators)

Beyond the preview

Go deeper on Splicing factor 3B subunit 3 (SF3B3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Splicing factor 3B subunit 3 (SF3B3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call